(Q47771329)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Živko Popov

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sylvie Bastuji-Garin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Sixtina Gil-Diez-De-Medina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Andras Hoznek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Marie-Aude Lefrere-Belda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Claude C Abbou

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Dominique K Chopin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

93-101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

Expression of epidermal growth factor (EGF) and the EGF receptor in human tissues

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Original Articles: Bladder Cancer: Long-Term Outcome Related to Epidermal Growth Factor Receptor Status in Bladder Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Evaluation of epidermal growth factor receptors in bladder tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Reappraisal of the biological role of epidermal growth factor receptor in transitional cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

The voiding pattern in infants with dilating reflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

The epidermal growth factor receptor and the prognosis of bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Immunohistochemical detection of the epidermal growth factor receptor in paraffin-embedded human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.01.001

10.1016/J.UROLONC.2004.01.001

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082004%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference